why choose us

First received: March 16, 2023

Clinical Trial: Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome

Study Status: Completed

Recruit Status: RECRUITING

Condition: Netherton Syndrome

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Open Label Study of QRX003 Lotion in Subjects With Netherton Syndrome

Brief Summary: To assess the safety, tolerability, and efficacy of QRX003 lotion (4%) when added to standard of care treatment regimen, including systemic therapy in subjects with Netherton syndrome

Read more